USA flag logo/image

An Official Website of the United States Government

Nonhazardous Urine Pretreatment Method for Future Exploration Systems

Award Information

Agency:
National Aeronautics and Space Administration
Branch:
N/A
Award ID:
88079
Program Year/Program:
2008 / SBIR
Agency Tracking Number:
074285
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
UMPQUA Research Company
P.O. Box 609 Myrtle Creek, OR 97457-0102
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: Yes
 
Phase 1
Fiscal Year: 2008
Title: Nonhazardous Urine Pretreatment Method for Future Exploration Systems
Agency: NASA
Contract: NNX08CC32P
Award Amount: $100,000.00
 

Abstract:

A novel urine pretreatment that will prevent biological growth or chemical instabilities in urine without using hazardous chemicals is proposed. Untreated urine fosters biological growth, ammonia generation, creation of bio-solids, and inorganic precipitates, which foul water and air reclamation hardware. The current Russian system employs hexavalent chromium, a strong oxidant and carcinogen, and sulfuric acid to stabilize urine, while the American system utilizes potassium monopersulfate, another strong oxidant, sulfuric acid, and potassium benzoate. Urine stabilized in these respective manners requires triple and double containment, and chemical storage and handling become problematic due to the hazardous nature and low pH (1.3 ýý2.6) of these chemicals. These requirements significantly increase urine pretreatment ESM. The proposed pretreatment system consists of a simple flow-through Solid Phase Acid (SPA) bed containing sparingly soluble transition metal oxide particles for pH control, which combined with a soluble non-oxidizing biocide will provide long-term urine stabilization. This innovative system fulfills an unmet need for safe, efficient and automated urine pretreatment for current and future NASA missions. The Phase I effort will demonstrate the feasibility of this novel approach. The Phase II project will fully develop the process, including the design and testing of deliverable hardware for urine pretreatment.

Principal Investigator:

James R. Akse, Ph.D.
Principal Investigator
6518632653
akse@urcmail.net

Business Contact:

John S. Aker
Business Official
5418632655
aker@urcmail.net
Small Business Information at Submission:

UMPQUA Research Company
PO Box 609 Myrtle Creek, OR 97457

EIN/Tax ID: 930789314
DUNS: N/A
Number of Employees:
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No